Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1399 |
---|---|
Product Name | Anti-Human CD276 Recombinant Antibody(Enoblituzumab) |
Molecular Name | Enoblituzumab |
Alias | Anti-CD276 Recombinant Antibody, Research Grade Enoblituzumab |
CAS Number | 1353485-38-7 |
Target | CD276[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | ELISA, IHC, IF, IP, FCM, FuncS |
Buffer | PBS, pH7.5 |
Background | Enoblituzumab is a monoclonal antibody designed for the treatment of cancer. Formerly known as MGA271, the drug is a humanized IgG1κ monoclonal antibody recognizing human B7-H3, a member of the B7 family of immune regulators. This drug was developed by MacroGenics, Inc. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |